# clm_9B7DD75E016B

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 2,964,700,000 United States dollar  
valid_from: 2025-06-30  
valid_to: 2025-09-30  
published: 2025-08-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_8AB184162D82  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly revenue: 2,964,700,000 United States dollar", as of 2025-06-30 (until 2025-09-30). Claim clm_9B7DD75E016B, https://asof.is/claim/clm_9B7DD75E016B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532025000216/0000875320-25-000216-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2025, filed 2025-08-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532025000216/0000875320-25-000216-index.htm (primary, SEC EDGAR 10-Q Q2 FY2025, published 2025-08-05)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_revenue | 2,770,200,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_9B7DD75E016B](/claim/clm_9B7DD75E016B.md) | [clm_1EC0DE7E99A1](/claim/clm_1EC0DE7E99A1.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.